
|Articles|April 26, 2004
Vigamox gets FDA approval for a supplemental list of susceptible pathogens
Fort Lauderdale-The FDA has approved a supplemental list of susceptiblepathogens to the in vitro labeling of Vigamox ophthalmic solution, AlconLaboratories announced Monday.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
2
FDA Clears IND application for GenEditBio’s GEB-101 in TGFBI corneal dystrophy
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4












































